3.0.0 3379 2022-11-01T13:51:00Z 2022-11-01T13:51:00Z House HR 2019-06-20 116 [Congressional Record Volume 165, Number 104 (Thursday, June 20, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHAKOWSKY:H.R. 3379.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3The Congress shall have Power . . . To regulate Commercewith foreign Nations, and among the several States, and withthe Indian Tribes.[Page H5007]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-06-21T18:21:51Z Referred to 2019-06-20T13:02:40Z Fair Care Act of 2020 116 4796 S 2020-10-05 Read twice and referred to the Committee on Finance. Related bill CRS Fair Care Act of 2020 116 8527 HR 2020-10-02 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, the Judiciary, Oversight and Reform, House Administration, Rules, the Budget, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2019-06-21 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-06-20 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-06-20 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-06-20 Introduced in House IntroReferral 1000 9 Library of Congress S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 N W000821 Rep. Westerman, Bruce [R-AR-4] Bruce Westerman R AR 4 2019-06-20 True D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 2019-06-20 True C001119 Rep. Craig, Angie [D-MN-2] Angie Craig D MN 2 2019-06-20 True D000399 Rep. Doggett, Lloyd [D-TX-35] LLOYD DOGGETT D TX 35 2019-06-20 True K000391 Rep. Krishnamoorthi, Raja [D-IL-8] Raja Krishnamoorthi D IL 8 2019-06-20 True K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2019-06-20 True C001084 Rep. Cicilline, David N. [D-RI-1] David Cicilline D RI N. 1 2019-06-20 True P000607 Rep. Pocan, Mark [D-WI-2] Mark Pocan D WI 2 2019-06-20 True R000515 Rep. Rush, Bobby L. [D-IL-1] BOBBY RUSH D IL L. 1 2019-06-20 True L000592 Rep. Levin, Andy [D-MI-9] Andy Levin D MI 9 2019-06-20 True M001206 Rep. Morelle, Joseph D. [D-NY-25] Joseph Morelle D NY D. 25 2019-06-20 True J000298 Rep. Jayapal, Pramila [D-WA-7] Pramila Jayapal D WA 7 2019-06-20 True T000481 Rep. Tlaib, Rashida [D-MI-13] Rashida Tlaib D MI 13 2019-06-20 True K000009 Rep. Kaptur, Marcy [D-OH-9] MARCY KAPTUR D OH 9 2019-06-20 True W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT 0 2019-06-20 True G000586 Rep. Garcia, Jesus G. "Chuy" [D-IL-4] Jesus Garcia D IL G. 4 2019-06-20 True O000172 Rep. Ocasio-Cortez, Alexandria [D-NY-14] Alexandria Ocasio-Cortez D NY 14 2019-06-25 False L000551 Rep. Lee, Barbara [D-CA-13] BARBARA LEE D CA 13 2019-07-12 False C001080 Rep. Chu, Judy [D-CA-27] Judy Chu D CA 27 2019-07-12 False N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2019-10-11 False R000606 Rep. Raskin, Jamie [D-MD-8] Jamie Raskin D MD 8 2019-10-11 False M001188 Rep. Meng, Grace [D-NY-6] Grace Meng D NY 6 2019-10-11 False Health Drug safety, medical device, and laboratory regulation Licensing and registrations Marketing and advertising Health 00 2019-06-20 Introduced in House 2020-01-25T18:55:48Z Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act

This bill allows biosimilars to be marketed five years after the reference brand-name biological product is licensed. Currently, brand-name biological products are provided a 12-year marketing-exclusivity period.

This shortened marketing-exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.

]]> PRICED Act Display Title PRICED Act Official Title as Introduced To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years. Introduced in House IH Short Title(s) as Introduced PRICED Act Introduced in House IH Short Title(s) as Introduced Price Relief, Innovation, and Competition for Essential Drugs Act Introduced in House IH Introduced in House 2019-06-20T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr3379ih/xml/BILLS-116hr3379ih.xml 2019-06-21 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.